$1.13
+0.00 (+0.00%)
Open$1.14
Previous Close$1.13
Day High$1.14
Day Low$1.10
52W High$2.62
52W Low$1.09
Volume—
Avg Volume1.81M
Market Cap181.54M
P/E Ratio—
EPS$-1.03
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+3,103.5% upside
Current
$1.13
$1.13
Target
$36.20
$36.20
$24.75
$36.20 avg
$54.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 52.28M | 89.42M | 45.49M |
| Net Income | 208.30M | 320.63M | -11,017,037 |
| Profit Margin | 398.4% | 378.5% | -24.2% |
| EBITDA | -219,705,299 | -356,969,444 | -13,211,435 |
| Free Cash Flow | — | — | -11,236,120 |
| Rev Growth | -41.5% | -41.5% | +9.2% |
| Debt/Equity | 0.84 | 0.84 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |